Patent Monopolies Driving High U.S. Drug Prices: Study

TUESDAY, Aug. 23, 2016 — Prescription drug prices are skyrocketing in the United States due in large part to government regulations, a new analysis finds.
These regulations allow drug manufacturers to charge monopolistic prices that aren’t opposed…
Source: Topamax